Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.
about
Staphylococcus aureus Toxins and Diabetic Foot Ulcers: Role in Pathogenesis and Interest in DiagnosisFecal Carriage of Staphylococcus aureus in the Hospital and Community Setting: A Systematic ReviewA Case of Acute Osteomyelitis: An Update on Diagnosis and TreatmentCoordinated Molecular Cross-Talk between Staphylococcus aureus, Endothelial Cells and Platelets in Bloodstream InfectionStructure, Biology, and Therapeutic Application of Toxin-Antitoxin Systems in Pathogenic BacteriaStuck in the Middle: Fibronectin-Binding Proteins in Gram-Positive BacteriaAntibacterial Action of Curcumin against Staphylococcus aureus: A Brief ReviewStaphylococcal adaptation to diverse physiologic niches: an overview of transcriptomic and phenotypic changes in different biological environmentsExtracellular Fibrinogen-binding Protein (Efb) from Staphylococcus aureus Inhibits the Formation of Platelet-Leukocyte ComplexesOsteomyelitis: Recent advances in pathophysiology and therapeutic strategiesChanges in the Cytoplasmic Composition of Amino Acids and Proteins Observed in Staphylococcus aureus during Growth under Variable Growth Conditions Representative of the Human Wound SiteTransmission of Staphylococcus aureus from Humans to Green Monkeys in The Gambia as Revealed by Whole-Genome SequencingIn Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus BiofilmsPeptides from Tetraspanin CD9 Are Potent Inhibitors of Staphylococcus Aureus Adherence to KeratinocytesEpidemiology and Management of Acute Haematogenous Osteomyelitis in a Tertiary Paediatric Center.Myricetin protects Galleria mellonella against Staphylococcus aureus infection and inhibits multiple virulence factors.sRNA and cis-antisense sRNA identification in Staphylococcus aureus highlights an unusual sRNA gene cluster with one encoding a secreted peptideToll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactants.Lysibodies are IgG Fc fusions with lysin binding domains targeting Staphylococcus aureus wall carbohydrates for effective phagocytosis.Location, Location, Location: Five Facts about Tissue Tropism and Pathogenesis.Phenylketonuria and Gut Microbiota: A Controlled Study Based on Next-Generation Sequencing.Characterization of Staphylococcus aureus isolates from raw milk sources in Victoria, Australia.Staphylococcus aureus Tissue Infection During Sepsis Is Supported by Differential Use of Bacterial or Host-Derived Lipoic Acid.Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.Sensitive and inexpensive digital DNA analysis by microfluidic enrichment of rolling circle amplified single-moleculesNovel Potentiators for Vancomycin in the Treatment of Biofilm-Related MRSA Infections via a Mix and Match Approach.Stroke caused by an inflammatory thrombus: a case reportDifferential Contributions of the Complement Anaphylotoxin Receptors C5aR1 and C5aR2 to the Early Innate Immune Response against Staphylococcus aureus Infection.Bacterial Cytological Profiling (BCP) as a Rapid and Accurate Antimicrobial Susceptibility Testing Method for Staphylococcus aureus.The T Cell Response to Staphylococcus aureusCAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.Role of the ESAT-6 secretion system in virulence of the emerging community-associated Staphylococcus aureus lineage ST398.Bad news itself or just the messenger? The high mortality of Fusobacterium spp. infections is related to disseminated malignancy and other comorbiditiesEpidemiology of antimicrobial resistance in bloodstream infections.Phenotypes and Virulence among Staphylococcus aureus USA100, USA200, USA300, USA400, and USA600 Clonal Lineages.Structure of the host-recognition device of Staphylococcus aureus phage ϕ11Staphylococcus aureus Phenol-Soluble Modulins Impair Interleukin Expression in Bovine Mammary Epithelial Cells.Identification and treatment of the Staphylococcus aureus reservoir in vivoIn Vivo Pharmacodynamic Target Assessment of Delafloxacin against Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae in a Murine Lung Infection Model.Host Physiologic Changes Induced by Influenza A Virus Lead to Staphylococcus aureus Biofilm Dispersion and Transition from Asymptomatic Colonization to Invasive Disease
P2860
Q26741281-E518A76F-ED57-49BE-9DC8-2B177F062960Q26744688-7DB45DF2-D528-49B0-93E9-66AEE6FC9E99Q26744814-D54C895F-D6CE-4931-9337-18092D9A29DDQ26774302-0C08773A-FA99-4349-9D7E-9D5370B3BEAAQ28066978-5A54645B-3F4A-41DB-9DA6-D35C6202C5D2Q28067173-F126E2DA-41BE-4FAC-BD39-B90BA250E5FBQ28077693-3EF64F01-1FDE-41DA-A814-50A9C80253DBQ28087340-34F97DF3-64D1-4492-AD49-3534EC2B6235Q28115532-D9D67FD9-904B-47DD-A98E-50A49521F412Q28393093-4307CAED-047E-4EC1-B5C2-18580588953BQ28552820-1C86B03B-4A86-4313-9BCA-744720D9D027Q28828876-7139DA33-BE54-41DC-B72F-FA90CAF3A224Q28834620-231E8A3B-6328-40F3-84CE-8FF486E95104Q30376325-630AF53F-BD0B-454A-9FFA-D7C8E8A53346Q33748544-7BA12706-FC73-4067-BB35-59D5B395886EQ33767539-0945E8DF-D78E-4E2A-9BDB-B79B3F6E9FD5Q33870596-1FB3A659-C61C-4F80-A751-6016B3077A90Q34535716-5F37BC71-3A2B-49EE-A5FD-568ED05FF0EDQ34555552-51B2A2C6-0008-4C2F-9211-225A33891C73Q36030338-06EFCEB2-EA46-4537-A500-28EB3CA5F7DDQ36060094-BC97C755-2F8F-453D-8CB4-A0002128E3B9Q36090155-5028A3F9-4A34-4ABC-AECA-6B9204200732Q36152845-6D45BD7F-D9B6-4C19-9A2C-00CCC277C48FQ36181397-7A751712-0927-4819-83A3-06603DF60166Q36246844-E119E76E-2668-49E6-B96B-A4165781075FQ36254829-63B898A8-61F6-4A9D-9E44-D2CE8C7B9E1CQ36283357-FFE23CDE-D5DE-42DE-BA4C-78ADFD613A1BQ36409375-12883C17-0606-4311-A04F-DE173D8E4499Q36645037-4F84D827-6C63-4A26-887B-3B061329D2FDQ36735452-7346397D-4931-4B8A-BC8D-31EEBC3A296AQ36748977-79488E39-DCE1-4C6E-BD46-47BAD304CC31Q36835518-1B2D98D5-831C-418F-B355-9D15A8D3BEA5Q36895148-B38F018D-1D4F-4B55-9251-2AFAA62758B4Q36913239-35836AEA-6C6B-49A3-96FC-D04012401562Q36986495-D53B0412-D730-4A7B-A222-4AA0AE15474DQ36990732-39537158-FE57-4022-AF36-4AD856A7D143Q37002316-FF61773F-BE99-4538-B602-8FD58B05B0A3Q37047344-5FFFF002-8C11-4ADB-8AF3-D17BCF6EB1CEQ37120092-6167F5A4-9185-48AC-9CC4-2B6FFF5BBA89Q37168719-D7982F30-A35A-48A0-8C30-F3FDAE539BD5
P2860
Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Staphylococcus aureus infectio ...... anifestations, and management.
@ast
Staphylococcus aureus infectio ...... anifestations, and management.
@en
Staphylococcus aureus infectio ...... anifestations, and management.
@nl
type
label
Staphylococcus aureus infectio ...... anifestations, and management.
@ast
Staphylococcus aureus infectio ...... anifestations, and management.
@en
Staphylococcus aureus infectio ...... anifestations, and management.
@nl
prefLabel
Staphylococcus aureus infectio ...... anifestations, and management.
@ast
Staphylococcus aureus infectio ...... anifestations, and management.
@en
Staphylococcus aureus infectio ...... anifestations, and management.
@nl
P2093
P2860
P356
P1476
Staphylococcus aureus infectio ...... manifestations, and management
@en
P2093
Emily Eichenberger
Thomas L Holland
Vance G Fowler
P2860
P304
P356
10.1128/CMR.00134-14
P407
P577
2015-07-01T00:00:00Z